WallStreetZenWallStreetZen

NASDAQ: STRR
Star Equity Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their STRR stock forecasts and price targets.

Forecast return on equity

Is STRR forecast to generate an efficient return?

Company
1.54%
Industry
-3.09%
Market
72.5%
STRR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is STRR forecast to generate an efficient return on assets?

Company
1.05%
Industry
9.24%
STRR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

STRR earnings per share forecast

What is STRR's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.78
Avg 2 year Forecast
$0.28

STRR revenue forecast

What is STRR's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$55.1M+9.38%
Avg 2 year Forecast
$81.0M+60.79%
STRR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

STRR revenue growth forecast

How is STRR forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
9.38%
Industry
5.3%
Market
8.67%
STRR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
STRR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

STRR vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
STRR$2.95N/AN/A
PRPO$5.96N/AN/A
TRIB$1.11N/AN/A
XWEL$1.40N/AN/A
TTOO$0.58$5.00+763.56%Hold
View Top Diagnostic & Research Stocks

Star Equity Holdings Stock Forecast FAQ

What is STRR's earnings growth forecast for 2024-2025?

(NASDAQ: STRR) Star Equity Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 39.14%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 41.19%.

Star Equity Holdings's earnings in 2024 is -$8,231,000.On average, 1 Wall Street analyst forecast STRR's earnings for 2024 to be -$2,510,375, with the lowest STRR earnings forecast at -$2,510,375, and the highest STRR earnings forecast at -$2,510,375.

In 2025, STRR is forecast to generate $901,160 in earnings, with the lowest earnings forecast at $901,160 and the highest earnings forecast at $901,160.

If you're new to stock investing, here's how to buy Star Equity Holdings stock.

What is STRR's revenue growth forecast for 2024-2025?

(NASDAQ: STRR) Star Equity Holdings's forecast annual revenue growth rate of 9.38% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.3%, and it is also forecast to beat the US market's average forecast revenue growth rate of 8.67%.

Star Equity Holdings's revenue in 2024 is $50,375,000.On average, 1 Wall Street analysts forecast STRR's revenue for 2024 to be $177,335,438, with the lowest STRR revenue forecast at $177,335,438, and the highest STRR revenue forecast at $177,335,438.

In 2025, STRR is forecast to generate $260,692,749 in revenue, with the lowest revenue forecast at $260,692,749 and the highest revenue forecast at $260,692,749.

What is STRR's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: STRR) forecast ROA is 1.05%, which is lower than the forecast US Diagnostics & Research industry average of 9.24%.

What is STRR's Earnings Per Share (EPS) forecast for 2024-2025?

(NASDAQ: STRR) Star Equity Holdings's current Earnings Per Share (EPS) is -$1.95. On average, analysts forecast that STRR's EPS will be -$0.78 for 2024, with the lowest EPS forecast at -$0.78, and the highest EPS forecast at -$0.78. In 2025, STRR's EPS is forecast to hit $0.28 (min: $0.28, max: $0.28).

What is STRR's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: STRR) forecast ROE is 1.54%, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.